MEDIA ALERT: DENVER/July 31, 2024 – Morris Animal Foundation and the Cornell Veterinary Biobank will partner to improve access and provide additional quality control of biological samples collected as part of the Golden Retriever Lifetime Study.
"The partnership with Cornell University ensures our samples meet the highest quality standards for use in groundbreaking scientific studies that benefit dog health,” said Dr. Julia Labadie, Principal Investigator, Golden Retriever Lifetime Study.
The Cornell Veterinary Biobank, a premier animal biobank and the first to achieve ISO 20387 accreditation, a rigorous international standard for biobanking operations. The Cornell team will provide expert biobanking services critical to the success of the Study and the research community at large.
The Golden Retriever Lifetime Study is an innovative initiative composed of owner- and veterinarian-reported data and annual biological samples from a cohort of privately owned dogs living throughout the lower 48 United States.
The Study's primary objective is to identify the incidence and risk factors for osteosarcoma, hemangiosarcoma, lymphoma and high-grade mast cell tumors. The Foundation is also closely monitoring the incidence of histiocytic sarcoma as it has emerged as a cancer of interest.
Secondary goals include studies of all other cancers and common significant diseases, including hypothyroidism, epilepsy, allergy disorders, hip dysplasia, congestive heart failure and renal failure.
About Morris Animal Foundation
Morris Animal Foundation’s mission is to bridge science and resources to advance the health of animals. Founded in 1948 and headquartered in Denver, it is one of the largest nonprofit animal health research organizations in the world, funding nearly $160 million in more than 3,000 critical animal health studies to date across a broad range of species. Learn more at morrisanimalfoundation.org.
About Cornell University College of Veterinary Medicine
The Cornell University College of Veterinary Medicine (CVM) is an international leader in veterinary education, public health, biomedical research, and animal medicine. We educate nearly 700 students each year through doctoral programs in veterinary medicine, biomedical and biological sciences, and a Master of Public Health program. Clinicians see approximately 100K patients yearly at our seven hospitals and on farms and field settings, and we have a robust biomedical research program funded by NIH and other federal sources. We advance environmental and human health and provide national laboratory diagnostic testing and wildlife surveillance and protection. The Cornell Veterinary Biobank (CVB) serves as a core resource for the College of Veterinary Medicine and is dedicated to accelerating biomedical and translational research with the potential to improve both animal and human health. The CVB collects, stores, processes, and distributes high-quality biospecimens and associated data, setting the global standard by being the first biobank to ever achieve ISO 20387 accreditation.
Media Contact: Lindsey Washington
